HOME >> MEDICINE >> NEWS
The Lancet Neurology November press release

It is well known in media circles that including the word "sex" in a headline is a sure-fire way of attracting the attention of potential readers. It is understandable, therefore, why a paper published in the Journal of Neurology, Neurosurgery, and Psychiatry (JNNP) entitled "Is multiple sclerosis a sexually transmitted infection?" was well covered by the UK media on Sept 19. Unfortunately, however, the news stories understandably upset many patients with multiple sclerosis. This month's Leading edge (http://neurology.thelancet.com/journal/vol1/iss7/full/lneu.1.7.the_leading_edge.22731.1) discusses who, if anyone, was to blame for this and asks what the lay media, academic journals, scientists, and the general public should expect from each other.

Cyclo-oxygenase inhibitors and Alzheimer's: are we well adapted?

On Sept 4, 2002, the Public Citizen Health Research Group (PCHRG; Washington, DC, USA) sent a letter to US Secretary of Health and Human Services, Tommy Thompson, regarding the Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT), which is sponsored by the National Institute on Aging. In the letter, PCHRG called ADAPT "misleading and incomplete..." and said that there are "major problems...with the scientific premise upon which the study is based". In a Reflection and Reaction article (http://neurology.thelancet.com/journal/vol1/iss7/full/lneu.1.7.reflection_and_reaction.22777.1) Giulio Maria Pasinetti and colleagues (Neuroinflammation Research Laboratories, Mount Sinai School of Medicine, New York, USA) summarise the recent evidence supporting preventative anti-inflammatory clinical trials in Alzheimer's disease,and objectively revisit the key studies cited by PCHRG. The authors commentary reinforces the scientific pre
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-207-424-4949
Lancet
16-Oct-2002


Page: 1 2

Related medicine news :

1. The Lancet calls for the creation of a world institute for risk evaluation
2. The Lancet calls for creation of Intl Commission on Global Responses to Complex Emergencies
3. Majority of authors retract 1998 Lancet paper-Lancet editor points to implications
4. The Lancet Oncology (TLO)
5. The Lancet Infectious Diseases (TLID)
6. Lancet readers to join WHO election debate
7. The Lancet Oncology press release
8. The Lancet Neurology October press release
9. The Lancet neurology press release
10. The Lancet Neurology press release
11. The Lancet Oncology (TLO) and the Lancet Infectious Diseases (TLID)

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/16/2019)... LAUDERDALE, Fla. (PRWEB) , ... November 16, 2019 ... ... uniform provider to support AdventHealth, one of the nation’s largest faith-based health systems, ... kicked off a massive program implementation process – from product selection to fitting ...
(Date:11/14/2019)... ... 14, 2019 , ... Inland Detox, Inc. is proud of and grateful for ... President Vicente Fox of Mexico. The Chefs Latinos Guanajuato Festival Gastronomico was held at ... and raised on Saturday, November 9, 2019. The event featured a total of 18 ...
(Date:11/14/2019)... ... November 14, 2019 , ... BioInformatics Inc., part of Science ... market, today announced that 7 companies have been nominated for a Life Science ... , Since 2002, the Life Science Industry Awards have recognized manufacturers of the “tools ...
(Date:11/12/2019)... ... November 12, 2019 , ... AI for preventable harm ... report “Healthcare AI 2019 - Actualizing the Potential of AI”, which provides a ... and the only healthcare-focused AI company with enough clients to complete a full KLAS ...
(Date:11/12/2019)... ... November 12, 2019 , ... Certemy, a leading provider of ... of new features for custom branding. The new features allow customers to customize ... physical brand attributes. Customizable attributes include customer logo, an optional vanity URL, brand-specific ...
Breaking Medicine News(10 mins):
(Date:11/14/2019)... ... November 14, 2019 , ... ... double-blind, placebo-controlled human clinical trials using AstaZine® on brain health. , ... including feelings of depression, mental fatigue and overall mood state [psychological well-being] were ...
(Date:11/14/2019)... ... November 14, 2019 , ... Bioclinica Medical Imaging, ... it has reached a milestone in the company’s history: the company has contributed ... from biopharmaceutical clients for therapies and indications subsequently approved by the U.S. Food ...
(Date:11/12/2019)... ... 2019 , ... MedMark Treatment Centers, a BayMark Health Services ... Cincinnati, OH suburb of Milford. MedMark Milford provides proven treatment for adults struggling ... 749C State Route 28 in Milford, is now accepting patients. , “In ...
Breaking Medicine Technology:
Cached News: